Peptides produced in the gastrointestinal tract play a crucial role in regulating metabolic processes and systemic health, with incretins such as glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) being of particular interest currently. These peptides promise such powerful benefits that their receptor agonists (e.g., semaglutide, tirzepatide, retatrutide) are exploding in use with stunning results that extend well beyond weight loss and blood sugar regulation.Recent research highlights the intricate interplay between these gut-derived peptides, gastrointestinal health, liver health, and the gut microbiome, deepening our understanding of the microbiome’s pivotal role in maintaining health across the body. Join us Thursday, Feb 20, at noon for a “Lunch and Learn” featuring Dr. Jocelyn Strand, ND, Senior Director of Clinical Education and Research for Biocidin Botanicals. Discover why peptides must be used appropriately and as part of a strategy for whole-body health to see their full benefit and garner lasting results
You’ll leave with a better understanding of:
● Mechanisms by which a myriad of gut peptides operate.
● The critical influence of the microbiome and bile acids on the production, release, and efficacy of gut peptides, including GLP-1 and GIP.
● Potential therapeutic strategies targeting the microbiome to manage whole-body health.
Jocelyn Strand, ND, is Senior Director of Clinical Education and Research for Biocidin Botanicals. She brings both a reverence for botanicals and a passion for science to her role. Dr. Strand monitors and participates in research, trains clinicians, creates clinical content, and is a respected and engaging speaker. Before joining Biocidin Botanicals in 2019, Dr. Strand was a primary care provider in private practice for 11 years through the Minnesota Board of Medical Practice. She specialized in GI system disorders, Lyme disease, and autoimmune conditions.